Dublin, Oct. 17, 2022 (GLOBE NEWSWIRE) -- The "Manufacturing Execution System Providers in Healthcare by Type of Deployment, Type of End-User and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.
This report features an extensive study of the current market landscape and future opportunity for players engaged in offering manufacturing execution systems in the healthcare sector. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain.
Every year, the healthcare industry generates a massive amount of data. In fact, the healthcare data currently constitutes around 30% share of the global data volume. Further, it is estimated that, by 2025, the data generated via the healthcare sector will rise at an annualized growth rate of 36%.
However, it is important to consider that the constant management of such enormous volumes of data is a tedious and challenging process. Specifically, management and handling of huge datasets in the healthcare industry often requires a large workforce of specialized personnel.
According to the American Hospital Association, by 2026, there is likely to be a shortage of 3.2 million healthcare workers. The continuously growing data, coupled to the projected deficit of healthcare workers, would inadvertently generate pressure on healthcare manufacturers to adopt novel tools / technologies that can improve management efficiency and better utilize the available, expensive resources.
Moreover, increasing complexity of healthcare manufacturing operations, along with growing stringency and frequent changes in regulatory requirements has created a dire need for adoption of automated solutions, such as manufacturing execution systems (MES).
In recent years, several healthcare stakeholders have actively undertaken initiatives to incorporate a manufacturing execution system into their production lines, with an aim to connect, monitor and control the complex manufacturing process. In addition, players are integrating advanced technologies, including internet of thing (IoT) and artificial intelligence (AI), in order to collect and analyze large volume of data from various sources, as well as to produce value in the form of insights, predictions and actions.
According to industry experts, manufacturing execution systems has the potential to reduce 10%-30% of the overall production cost depending on the type of industry. It has further been observed that companies are increasingly adopting cloud-based manufacturing execution system, to overcome the challenges associated with growing complexity of processes and global expansion of businesses.
Specifically, cloud-based manufacturing execution systems integrate real-time information of different production floors and promotes collaboration. Considering the rising demand for such systems, presently, more than 75 companies claim to offer manufacturing execution systems, based on several deployment models, to the healthcare sector. It is worth mentioning that, in the past few years, substantial acquisition activity has been reported in the manufacturing execution systems market, as players strive to become one-stop-shops, to cater to the diverse needs of the healthcare sector.
Driven by the ongoing innovation in the industry, as well as the rise in demand for automated solutions, the manufacturing execution system providers market for the healthcare sector is likely to witness positive growth over the coming years.
Key Questions Answered
- Who are the key players engaged in offering manufacturing execution systems for the healthcare sector?
- Which type of deployment is most commonly adopted by manufacturing execution system providers in the healthcare sector?
- What is the relative competitiveness of different manufacturing execution system providers for the healthcare sector?
- Which partnership models are most commonly being adopted by stakeholders engaged in this industry?
- What is the unmet need within this domain and how can the ongoing advancements in technologies enable enhanced efficiency of overall manufacturing execution systems?
- How is the current and future opportunity likely to be distributed across key market segments?
Key Topics Covered:
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. MARKET LANDSCAPE
4.1. Manufacturing Execution System Providers in Healthcare: Market Overview
4.2. List of Manufacturing Execution System Providers in Healthcare
4.3. Analysis by Year of Establishment
4.4. Analysis by Company Size
4.5. Analysis by Location of Headquarters
4.6. Analysis by Type of Deployment
4.7. Analysis by Integrating Software
4.8. Analysis by Type of License
4.9. Analysis by Type of End User
4.10. Analysis by Key Features
4.11. Analysis by Type of Service(s) Offered
4.12. Analysis by Quality Certifications Received
5. KEY INSIGHTS
5.1. Analysis by Year of Establishment and Region of Headquarters
5.2. Analysis by Company Size and Type of Deployment
5.3. Analysis by Type of License and End User
5.4. Analysis by Company Size and Key Features
5.5. Analysis by Year of Establishment, Company Size, Type of Deployment and Quality Certifications Received (4D Bubble Chart)
6. PARTNERSHIPS AND COLLABORATIONS
6.1. Manufacturing Execution System Providers in Healthcare: Partnerships and Collaborations
6.2. Analysis by Year of Partnership
6.3. Analysis by Type of Partnership
6.4. Analysis by Year of Partnership and Type of Partnership
6.5. Analysis by Type of Partnership and Company Size
6.6. Key Players: Analysis by Number of Partnerships
6.7. Analysis by Type of Partner
6.8. Analysis by Country
6.9. Analysis by Region
6.10. Intercontinental and Intracontinental Deals
6.11. Analysis by Location of Headquarters of Partner
6.12. Analysis by Type of Partnership and Location of Headquarters of Partner
7. COMPANY COMPETITIVENESS ANALYSIS
7.1. Manufacturing Execution System Providers in Healthcare: Company Competitiveness Analysis
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Benchmarking of Portfolio Strength
7.5. Benchmarking of Partnership Activity
7.6. Company Competitiveness Analysis: Very Large Players
7.7. Company Competitiveness Analysis: Large Players
7.8. Company Competitiveness Analysis: Mid-Sized Players
7.9. Company Competitiveness Analysis: Small Players
8. COMPANY PROFILES
8.1. Andea
8.1.1 Company Overview
8.1.2. Technology Portfolio
8.1.3. Recent Developments and Future Outlook
8.2. Critical Manufacturing
8.2.1 Company Overview
8.2.2. Technology Portfolio
8.2.3. Recent Developments and Future Outlook
8.3. Dassault Systemes
8.3.1 Company Overview
8.3.2. Technology Portfolio
8.3.3. Recent Developments and Future Outlook
8.4. GE Digital
8.4.1 Company Overview
8.4.2. Technology Portfolio
8.4.3. Recent Developments and Future Outlook
8.5. Infor
8.5.1 Company Overview
8.5.2. Technology Portfolio
8.5.3. Recent Developments and Future Outlook
8.6. Korber
8.6.1 Company Overview
8.6.2. Technology Portfolio
8.6.3. Recent Developments and Future Outlook
8.7. Rockwell Automation
8.7.1 Company Overview
8.7.2. Technology Portfolio
8.7.3. Recent Developments and Future Outlook
9. VALUE CREATION FRAMEWORK: A STRATEGIC GUIDE TO ADDRESS UNMET NEED FOR MANUFACTURING EXECUTION SYSTEMS
9.1. Unmet Need for Manufacturing Execution Systems in the Healthcare Industry
9.2. Key Assumptions and Methodology
9.3. Key Tools and Technologies
9.3.1. Technology 1
9.3.2. Technology 2
9.3.3. Technology 3
9.3.4. Technology 4
9.4. Extent of Innovation versus Associated Risks
9.5 Concluding Remarks
10. MARKET FORECAST
10.1. Key Assumptions and Forecast Methodology
10.2. Forecasted Market Segments
10.3. Manufacturing Execution System Providers in Healthcare Market, 2022-2035
10.4. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of Deployment, 2022-2035
10.4.1. Manufacturing Execution System Providers in Healthcare Market for Cloud Solutions
10.4.2. Manufacturing Execution System Providers in Healthcare Market for Corporate Datacenter Solutions
10.4.3. Manufacturing Execution System Providers in Healthcare Market for Hybrid Solutions
10.4.4. Manufacturing Execution System Providers in Healthcare Market for On Premise Solutions
10.5. Manufacturing Execution System Providers in Healthcare Market: Analysis by Type of End User, 2022-2035
10.5.1. Manufacturing Execution System Providers in Healthcare Market for Life science / Biotechnology Companies
10.5.2. Manufacturing Execution System Providers in Healthcare Market for Medical Device Providers
10.5.3. Manufacturing Execution System Providers in Healthcare Market for Pharmaceutical Companies
10.5.4. Manufacturing Execution System Providers in Healthcare Market for Other End Users
10.6. Manufacturing Execution System Providers in Healthcare Market: Analysis by Geography, 2022-2035
10.6.1. Manufacturing Execution System Providers in Healthcare Market in North America, 2022-2035
10.6.2. Manufacturing Execution System Providers in Healthcare Market in Europe, 2022-2035
10.6.3. Manufacturing Execution System Providers in Healthcare Market in Asia, 2022-2035
10.6.4. Manufacturing Execution System Providers in Healthcare Market in Latin America, 2022-2035
10.6.5. Manufacturing Execution System Providers in Healthcare Market in MENA, 2022-2035
10.6.6. Manufacturing Execution System Providers in Healthcare Market in Rest of the World, 2022-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
12.1. NoMuda
12.1.1. Company Snapshot
12.1.2. Interview Transcript: Philip Borland (Chief Executive Officer)
12.2. ORDINAL Software
12.2.1. Company Snapshot
12.2.2. Interview Transcript: Carine van Godtsenhoven (Chief Marketing Officer)
12.3. Trunovate
12.3.1. Company Snapshot
12.3.2. Interview Transcript: Yaron Halfon (Director of Sales)
13. APPENDICES I: OTHER FIGURES
13.1. Market Overview
13.2. Key Insights
13.3. Partnerships and Collaborations
13.4. List of Figures
14. APPENDICES II: TABULATED DATA
15. APPENDICES III: LIST OF COMPANIES
For more information about this report visit https://www.researchandmarkets.com/r/ilfp1b
